General Information
Product name
Terbinafine Tablets USP 250 mg
CAS No.
78628-80-5
Manufacturer Name
Plot No. B5(Part) and B6(Part)
Icons in SDS
Company Information
company name
Plot No. B5(Part) and B6(Part)
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
Emergency overview Light pink with mottled surface, round, biconvex tablets debossed with “501” on one side and plain on the other side. Odor: No data available WARNING! May be harmful if swallowed. Accidental ingestion of large amounts may be harmful.
Principle Routes of Exposure
Ingestion
Potential health effects
Inhalation: Not expected to be an inhalation hazard in final pharmaceutical form. Eye contact: Not expected to be a hazard to the eye in final Skin contact: Not expected to be a hazard to the skin. Can cause hypertension reactions resulting in rash, redness, itching and inflammation. Ingestion: May be harmful if ingested. Ingestion may cause liver damage, taste disturbances, gastrointestinal effects and other systemic effects. Effects of The potential for exposure is reduced in finished overexposure pharmaceutical form. Overexposure by ingestion may cause nausea, vomiting, abdominal pain, dizziness, rash, frequent urination and headache. Target Organs Gastrointestinal Tract, Liver
